12th Apr 2006 07:01
Cyprotex PLC12 April 2006 Press Release 12 April 2006 Cyprotex Plc ("Cyprotex" or "the Company") Issue of 97,669 shares pursuant exercise of options Cyprotex PLC (AIM: CRX), a drug discovery technology and information company,today announces that it has issued 97,669 new ordinary shares of 0.1p each ("new Ordinary Shares") pursuant to the exercise of options. The issue of the new Ordinary Shares is subject to the new Ordinary Shares beingadmitted to trading on AIM, application for which has been made. Trading in thenew Ordinary Shares, which will rank pari passu in all respects with theexisting ordinary shares, is expected to commence on 14 April, 2006. - Ends - For further information: Cyprotex PLCRobert Morrisson Atwater, Tel: +44 (0)1625 505 100Chairman & Chief Executive [email protected] www.cyprotex.com Code SecuritiesCharles Walker Tel: +44 (0) 207776 [email protected] www.codesecurities.com------------------------- Media enquiries:Abchurch CommunicationsHeather Salmond Tel: +44 (0) 207398 7700 [email protected] www.abchurch-group.co------------------------- This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
CRX.L